These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18365421)

  • 1. Renal graft loss in recipients with at least one year of function and donor specific antibody (DSA).
    Cicciarelli J; Shah T; Koss M; Houston K; Narahghi R
    Clin Transpl; 2006; ():539-40. PubMed ID: 18365421
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft loss in three patients with donor-specific antibody (DSA).
    Qasi Y; Hermes M; Cicciarelli J
    Clin Transpl; 2006; ():541. PubMed ID: 18365422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in donor-specific alloantibody production after transplantation.
    Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2715-7. PubMed ID: 18021966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation.
    Lefaucheur C; Suberbielle-Boissel C; Hill GS; Nochy D; Andrade J; Antoine C; Gautreau C; Charron D; Glotz D
    Contrib Nephrol; 2009; 162():1-12. PubMed ID: 19001809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?
    Gupta A; Iveson V; Varagunam M; Bodger S; Sinnott P; Thuraisingham RC
    Transplantation; 2008 Apr; 85(8):1200-4. PubMed ID: 18431242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
    Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay.
    Phelan D; Mohanakumar T; Ramachandran S; Jendrisak MD
    Hum Immunol; 2009 Aug; 70(8):584-8. PubMed ID: 19477211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
    Wahrmann M; Bartel G; Exner M; Regele H; Körmöczi GF; Fischer GF; Böhmig GA
    Transpl Int; 2009 Oct; 22(10):982-9. PubMed ID: 19619171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P; Hönger G; Mayr M; Steiger J; Hopfer H; Schaub S
    Transplantation; 2009 Jun; 87(11):1681-8. PubMed ID: 19502960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X; Ishida H; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications.
    Briggs D; Zehnder D; Higgins RM
    Contrib Nephrol; 2009; 162():107-16. PubMed ID: 19001818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific antibody detection for diagnosis of antibody-mediated rejection in kidney transplantation.
    Gautreau C; Suberbielle C; Andrade J; Charron D
    Clin Transpl; 2006; ():502. PubMed ID: 18365411
    [No Abstract]   [Full Text] [Related]  

  • 15. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L; Lee PC; Everly MJ; Terasaki PI
    Clin Transpl; 2008; ():171-87. PubMed ID: 19711514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M; Bosio E; Ancona E; Cozzi E
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
    Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
    Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
    Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC
    Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How much donor human leukocyte antigen-specific antibody is too much for a renal transplant?
    Vaughan R; Shaw O
    Transplantation; 2008 Apr; 85(8):1081-2. PubMed ID: 18431224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.